Ohio State University Nisonger Center Clinical Trials Program — Columbus, Ohio

Ohio State University Nisonger Center Clinical Trials Program is a clinical research site located in Columbus, Ohio, United States 43210.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Ohio State University Nisonger Center Clinical Trials Program has participated in 2 clinical trials.

Therapeutic areas: Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit Hyperactivity Disorder.

Sponsors: Supernus Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ohio State University Nisonger Center Clinical Trials Program?

Ohio State University Nisonger Center Clinical Trials Program has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ohio State University Nisonger Center Clinical Trials Program conducted?

Ohio State University Nisonger Center Clinical Trials Program has 2 clinical trials on record. Their work covers Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit Hyperactivity Disorder.

Is Ohio State University Nisonger Center Clinical Trials Program accredited by Crixeo Health?

Ohio State University Nisonger Center Clinical Trials Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ohio State University Nisonger Center Clinical Trials Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.